Fructose 1,6-bisphosphate inhibits osteoclastogenesis by attenuating RANKL-induced NF- κB/NFATc-1

ConclusionAltogether these data show a protective role of a natural glycolytic intermediate in bone homeostasis that may have therapeutic benefit for osteolytic diseases.

Source: Inflammation Research - March 28, 2019 Category: Research Source Type: research